MedPath

A clinical study to see the effect of some Ayurvedic formulation in the form of nasal administration in the treatment of simple myopia.

Phase 2
Completed
Conditions
Health Condition 1: H521- Myopia
Registration Number
CTRI/2020/11/029057
Lead Sponsor
Sane Guruji Arogya Kendra
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
74
Inclusion Criteria

1) Patient having signs and symptoms of

Prathama and Dwitiya Patalagata

Timir a will be included i.e blurriness, difficult to distant vision, visual

hallucination.

2) The patient of age from 19 to 40 years,irrespective of gender

3) Patient who have low myopia

3D in both eyes.

4)Patients having a vision 6/9

or less i.e. 6/12, 6/18, 6/24, 6/36, 6/60

5) Patient

yogya for Nasya karma

Exclusion Criteria

1) Know case of Myopia associated with other ocular diseases such as Cataract glaucoma, Retinal diseases, Iridocyclitis, Vitreous opacity, Chorioretinitis.

2) Know case of Congenital Myopia, Pathological Myopia and other types of Myopia.

3) Patients suffering from infectious diseases e.g. bacterial,viral or Fungalconjunctivitis, Blepharitis, Tubercular infection.

4) Refractive errors like Hypermetropia, Astigmatism.

5) Patients having refractive error more than -3D in both eyes

6) Patients having known case of Diabetes Mellitus, Hypertension, HIV,HBSAg Tuberculosis, Thyroid disorder.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
A clinical study to evaluate efficacy of Bhingaraja Taila Nasya in Prathama and Dwitiya Patalgata Timir w.r.t Simple Myopia. Parameter of efficacy will be visual acuity before and after treatmentTimepoint: Duration of therapy is 3 weeks for each patient and the total duration of trial is 18 month
Secondary Outcome Measures
NameTimeMethod
comparison between efficacy <br/ ><br>of Bhringaraja Taila Nasya and Abhijit Taila Nasya in <br/ ><br>Prathama and Dwitiya Patalgata Timir w.r.t <br/ ><br>Simple MyopiaTimepoint: Each patiennt will receive therapy for 3 weeks. Total duration of the study will 18 months.
© Copyright 2025. All Rights Reserved by MedPath